Annals of Surgical Oncology

, Volume 19, Issue 7, pp 2380–2387

Treatment Management of Small Renal Masses in the 21st Century: A Paradigm Shift

Authors

    • Cancer Prognostics and Health Outcomes UnitUniversity of Montreal Health Centre
  • Firas Abdollah
    • Cancer Prognostics and Health Outcomes UnitUniversity of Montreal Health Centre
    • Department of UrologyVita Salute San Raffaele University
  • Marco Bianchi
    • Department of UrologyVita Salute San Raffaele University
  • Quoc-Dien Trinh
    • Cancer Prognostics and Health Outcomes UnitUniversity of Montreal Health Centre
    • Vattikuti Urology InstituteHenry Ford Health System
  • Claudio Jeldres
    • Cancer Prognostics and Health Outcomes UnitUniversity of Montreal Health Centre
    • Department of UrologyUniversity of Montreal Health Centre
  • Rodolphe Thuret
    • Department of UrologyUniversity of Montpellier Health Center
  • Zhe Tian
    • Cancer Prognostics and Health Outcomes UnitUniversity of Montreal Health Centre
  • Shahrokh F. Shariat
    • Department of UrologyWeill Medical College of Cornell University
  • Francesco Montorsi
    • Department of UrologyVita Salute San Raffaele University
  • Paul Perrotte
    • Department of UrologyUniversity of Montreal Health Centre
  • Pierre I. Karakiewicz
    • Cancer Prognostics and Health Outcomes UnitUniversity of Montreal Health Centre
    • Department of UrologyUniversity of Montreal Health Centre
Urologic Oncology

DOI: 10.1245/s10434-012-2247-0

Cite this article as:
Sun, M., Abdollah, F., Bianchi, M. et al. Ann Surg Oncol (2012) 19: 2380. doi:10.1245/s10434-012-2247-0

Abstract

Background

Partial (PN) or radical nephrectomy (RN) represents the standard of care for patients with small renal masses. Active surveillance (AS) also may be considered. We examined the rates of PN, RN, and AS within a contemporary population-based cohort.

Methods

Using the surveillance, epidemiology and end results database, we identified 26,468 patients diagnosed with T1aN0M0 renal cell carcinoma, between years 1988 and 2008. Determinants of PN and AS were assessed using logistic regression analyses within surgically managed patients and within the entire cohort, respectively.

Results

Overall, 8,966 (34%), 14,705 (56%), and 2,797 (11%) patients underwent PN, RN, and AS, respectively. The rate of PN increased (4.7% in 1988 to 40.4% in 2008, P < 0.001), whereas the rate of RN decreased over time (92.9% in 1988 to 41.4% in 2008, P < 0.001). The rate of AS increased over time (2.4% in 1988 to 18.2% in 2008, P < 0.001). In multivariable analyses, the determinants for PN consisted of more contemporary year of diagnosis, younger patient age, male gender, Caucasian race, married status, and decreasing tumor size (all P ≤ 0.003). The determinants of AS consisted of more contemporary year of diagnosis, more advanced age, male gender, decreasing tumor size, and unmarried marital status (all P ≤ 0.001). Regional differences for management of localized RCC were detected.

Conclusions

It is encouraging that PN rates have increased in an eightfold fashion. Moreover, a fivefold increase was recorded for AS. These figures show a paradigm shift in the management of small renal masses.

Copyright information

© Society of Surgical Oncology 2012